195 related articles for article (PubMed ID: 20103680)
21. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
22. Ewing's sarcoma of bone tumor cells produces MCSF that stimulates monocyte proliferation in a novel mouse model of Ewing's sarcoma of bone.
Margulies BS; DeBoyace SD; Damron TA; Allen MJ
Bone; 2015 Oct; 79():121-30. PubMed ID: 26051470
[TBL] [Abstract][Full Text] [Related]
23. Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.
Remédio L; Carvalho T; Caiado F; Bastos-Carvalho A; Martins D; Duarte A; Yagita H; Dias S
PLoS One; 2012; 7(12):e52450. PubMed ID: 23285048
[TBL] [Abstract][Full Text] [Related]
24. Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents.
Stewart KS; Kleinerman ES
Sarcoma; 2011; 2011():165837. PubMed ID: 21785569
[TBL] [Abstract][Full Text] [Related]
25. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
Merchant MS; Woo CW; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
[TBL] [Abstract][Full Text] [Related]
26. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA
Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390
[TBL] [Abstract][Full Text] [Related]
27. The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
Landuzzi L; De Giovanni C; Nicoletti G; Rossi I; Ricci C; Astolfi A; Scopece L; Scotlandi K; Serra M; Bagnara GP; Nanni P; Lollini PL
Am J Pathol; 2000 Dec; 157(6):2123-31. PubMed ID: 11106584
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
Fuchs B; Inwards CY; Janknecht R
Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
[TBL] [Abstract][Full Text] [Related]
29. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation.
Boscolo E; Stewart CL; Greenberger S; Wu JK; Durham JT; Herman IM; Mulliken JB; Kitajewski J; Bischoff J
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2181-92. PubMed ID: 21757656
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
Lu Q; Lu M; Li D; Zhang S
Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
[TBL] [Abstract][Full Text] [Related]
31. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
[TBL] [Abstract][Full Text] [Related]
32. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.
Schulz GB; Wieland E; Wüstehube-Lausch J; Boulday G; Moll I; Tournier-Lasserve E; Fischer A
Stroke; 2015 May; 46(5):1337-43. PubMed ID: 25791711
[TBL] [Abstract][Full Text] [Related]
33. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.
Hu GH; Liu H; Lai P; Guo ZF; Xu L; Yao XD; Zheng JH; Liu M; Xu YF
Int J Clin Exp Pathol; 2014; 7(5):2143-52. PubMed ID: 24966922
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a clonal human extraskeletal Ewing's sarcoma cell line, EES1.
Hatori M; Doi H; Watanabe M; Sasano H; Hosaka M; Kotajima S; Urano F; Hata J; Kokubun S
Tohoku J Exp Med; 2006 Nov; 210(3):221-30. PubMed ID: 17077599
[TBL] [Abstract][Full Text] [Related]
35. Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Miyake K; Murakami T; Kiyuna T; Igarashi K; Kawaguchi K; Li Y; Singh AS; Dry SM; Eckardt MA; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Endo I; Eilber FC; Hoffman RM
J Cell Biochem; 2018 Jan; 119(1):967-972. PubMed ID: 28681998
[TBL] [Abstract][Full Text] [Related]
36. SDF-1α induces PDGF-B expression and the differentiation of bone marrow cells into pericytes.
Hamdan R; Zhou Z; Kleinerman ES
Mol Cancer Res; 2011 Nov; 9(11):1462-70. PubMed ID: 21911740
[TBL] [Abstract][Full Text] [Related]
37. The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.
Murakami T; Kiyuna T; Kawaguchi K; Igarashi K; Singh AS; Hiroshima Y; Zhang Y; Zhao M; Miyake K; Nelson SD; Dry SM; Li Y; DeLong JC; Lwin TM; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Cell Cycle; 2017 Jun; 16(11):1046-1052. PubMed ID: 28296559
[TBL] [Abstract][Full Text] [Related]
38. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
[TBL] [Abstract][Full Text] [Related]
39. [The immunogistochemical aspects of the angiogenesis by Ewing's sarcoma].
Akhundov ÉD; Muradov KhK; Alieva IO; Sadykhova GG
Khirurgiia (Mosk); 2011; (11):41-4. PubMed ID: 22408800
[TBL] [Abstract][Full Text] [Related]
40. Neovascularization in Ewing's sarcoma.
Mavrogenis AF; Vottis CT; Megaloikonomos PD; Agrogiannis GD; Theocharis S
Neoplasma; 2018 Mar; 65(3):317-325. PubMed ID: 29788734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
